In the blog dedicated to type 2 diabetes mellitus, we analyzed how blood glucose control cannot be considered an isolated goal, but must be part of a broader strategy involving diet, physical activity, body composition, muscle mass, sedentary behavior control, and management of the main cardiovascular risk factors.
Type 2 diabetes is indeed characterized by the progressive interaction between insulin resistance and altered pancreatic beta-cell function. This condition is frequently associated with visceral overweight, lipid metabolism alterations, ectopic fat accumulation, and a state of persistent activation of metabolic and inflammatory mediators. For this reason, a truly effective approach must consider the body as a whole.
Diet remains the primary modifiable tool. Carbohydrate quality, fiber content, food structure, and energy balance directly influence the postprandial glycemic response. At the same time, regular movement improves muscle glucose uptake, increases insulin sensitivity, and contributes to the maintenance of muscle mass.
As explored in the article dedicated to type 2 diabetes mellitus, diet, physical activity, and nutraceuticals, physical exercise and the reduction of sedentary behavior are fundamental components of metabolic prevention and management. Interest in certain plant extracts also stems from the possibility of acting, through different mechanisms, on multiple aspects of metabolic balance.
In this context, nutraceutical support can be considered as a complement to a healthy lifestyle. The goal is not to replace pharmacological therapy, but to support certain physiological processes involved in carbohydrate and lipid metabolism, appetite management, inflammatory balance, and protection against oxidative stress.
This guide proposes a rationale for the combination of MOLTITUDO® LUNAE, a vegan formulation based on Bromelain, Boswellia serrata, and Tetrahydrocurcuminoids, and Dimaloe, a plant-based capsule supplement containing Garcinia cambogia, Gymnema sylvestre, green coffee, Maitake, Griffonia, rosehip, vitamin E, and Piper longum.
The decision to combine the two products stems from the complementarity of their respective nutritional goals. On one hand, LUNAE is aimed at supporting the physiological balance of inflammatory processes and protecting against oxidative stress; on the other, Dimaloe brings together standardized extracts studied in relation to carbohydrate and lipid metabolism, appetite modulation, and energy balance control.
The formulation of LUNAE is consistent with Moltitudo's formulation philosophy, aimed at selecting plant active ingredients and reducing unnecessary ingredients. The product is a vegan supplement, formulated with Bromelain from Pineapple, Boswellia serrata, and Tetrahydrocurcuminoids. The official product sheet highlights the use of standardized ingredients and the absence of unnecessary preservatives and additives.
To learn more about the product and its characteristics, you can visit the official page: MOLTITUDO® LUNAE.
An in-depth look at the relationship between low-grade chronic inflammation and nutraceutical support with LUNAE is also available on the Moltitudo website: Silent chronic inflammation and nutraceutical support with LUNAE.
PRODUCT_ARTICLE
Proposed dosage
MOLTITUDO® LUNAE
1 tablet at lunch and 1 tablet at dinner, preferably during or immediately after the meal.
The total daily dose is therefore 2 tablets, corresponding to the maximum dose indicated on the product sheet for a split into two administrations. The formulation provides, for 2 tablets, pineapple stem extract with high enzymatic activity, standardized Boswellia serrata extract in boswellic acids, and Tetrahydrocurcuminoids. The official Moltitudo page lists LUNAE as a vegan supplement and states that the daily dose can be split into two doses with meals.
Dimaloe – schedule with a light dinner
2 capsules at breakfast and 2 capsules at lunch.
This schedule may be preferable when dinner is light, low in carbohydrates, or when the majority of the day's calories are concentrated in the first part of the day.
Dimaloe – schedule with a light lunch
2 capsules at breakfast and 2 capsules at dinner.
This schedule may be considered when lunch is particularly light or frugal and the evening meal represents the time when a larger portion of the daily food intake is consumed.
In both cases, the total daily dose remains 4 capsules, equal to the daily dose provided by the formulation.
The distribution of the dose in relation to the composition of the meals constitutes a nutritional rationale and does not replace the individual indications of the doctor or healthcare professional, especially in subjects with diagnosed diabetes or on hypoglycemic therapy.
The rationale for the combination of LUNAE and Dimaloe
An altered metabolism does not only involve blood glucose
In carbohydrate metabolism alterations, and particularly in type 2 diabetes, blood glucose represents only one of the parameters involved.
Insulin resistance can be associated with an increase in hepatic glucose production, reduced peripheral glucose utilization, lipid metabolism alterations, and the accumulation of visceral adipose tissue.
Metabolically active adipose tissue can contribute to the production of mediators involved in low-grade inflammation. For this reason, in recent years, scientific interest has increased in an approach that simultaneously takes into account metabolism, body composition, and the balance of inflammatory processes.
This is where the complementarity between LUNAE and Dimaloe lies.
LUNAE is not a product intended for the direct control of blood glucose. Its rationale lies in supporting the physiological balance of inflammatory processes and protecting against oxidative stress.
Dimaloe, on the other hand, brings together substances studied for their possible interaction with carbohydrate and lipid metabolism, appetite management, and energy balance.
The combination should not be interpreted as a diabetes therapy, but as a complementary nutraceutical strategy that fits into the broader context of a balanced diet, physical activity, and medical supervision.
MOLTITUDO® LUNAE: support for inflammatory balance
MOLTITUDO® LUNAE combines three components with complementary biological mechanisms: Bromelain, Boswellia serrata, and Tetrahydrocurcuminoids.
The formulation is vegan and uses selected plant-based ingredients. According to the official Moltitudo sheet, the daily dose of two tablets contains 1,000 mg of pineapple stem extract with an activity of 2,500 GDU, 500 mg of Boswellia serrata extract, and 140 mg of Tetrahydrocurcuminoids.
Bromelain: enzymatic activity and tissue well-being
Bromelain is a set of proteolytic enzymes obtained from Pineapple. It has been studied in relation to inflammatory processes, edema, and tissue recovery.
The biological rationale includes the modulation of mediators involved in the inflammatory response, tissue permeability, and processes associated with edema.
Bromelain's interest in the metabolic context derives indirectly from the existing relationship between a persistent inflammatory state, vascular function, body composition, and metabolism.
The available evidence is more consistent in certain musculoskeletal contexts and in recovery from edema and localized inflammation compared to the treatment of glycemic alterations. For this reason, in the proposed protocol, Bromelain is not considered a hypoglycemic agent, but a component aimed at supporting the physiological balance of tissues.
Boswellia serrata: boswellic acids and inflammatory pathways
The Boswellia serrata extract present in LUNAE is standardized in boswellic acids.
These compounds have been widely studied for their ability to modulate biochemical pathways involved in the inflammatory response, including 5-lipoxygenase and leukotriene production.
Several clinical studies have evaluated standardized Boswellia extracts especially in the context of pain and joint function.
The rationale for its presence in a protocol aimed at metabolic balance lies in the growing scientific attention towards the relationship between low-grade inflammation, visceral adipose tissue, and insulin resistance.
In this case too, it is important to maintain a clear distinction: Boswellia does not replace diabetes medications and should not be presented as a treatment for hyperglycemia.
Tetrahydrocurcuminoids: protection against oxidative stress
Tetrahydrocurcuminoids are reduced metabolites of curcumin characterized by chemical stability and biological activity.
Their interest concerns especially the ability to interact with mechanisms associated with oxidative stress and inflammatory processes.
Oxidative stress is one of the biological phenomena that accompany persistent hyperglycemia. Prolonged exposure to high levels of glucose can contribute to the formation of reactive oxygen species and the glycation of proteins and cellular structures.
Nutritional support for protection against oxidative stress does not naturally equate to the treatment of diabetes complications, but represents one of the possible areas of interest in research on plant compounds.
Why take LUNAE at lunch and dinner
The choice to distribute LUNAE in two administrations coincides with the method provided by the product sheet when using the daily dose of two tablets.
Taking it during the main meals also allows the product to be incorporated into a consistent nutritional routine.
Lunch and dinner generally represent two times when the body faces significant digestive and metabolic activity. The distribution of the dose allows avoiding the simultaneous intake of the entire daily quantity.
Regularity is particularly important when a supplement is incorporated into a broader lifestyle program. No nutraceutical can compensate on its own for an unbalanced diet, sedentary behavior, or chronic calorie excess.
Dimaloe: a multi-level formulation for metabolism and appetite
Dimaloe is formulated in plant-based capsules and provides, in the daily dose of four capsules, a combination of standardized plant extracts, a mushroom, vitamins, and bioactive substances.
The daily dose contains 833 mg of Garcinia cambogia extract standardized to 60% hydroxycitric acid, providing 500 mg of HCA; 400 mg of Gymnema sylvestre standardized to 25% gymnemic acids, equal to 100 mg of gymnemic acids; 222 mg of green coffee extract with 100 mg of chlorogenic acid.
The formulation is completed by Maitake standardized in polysaccharides, Griffonia standardized in 5-HTP, rosehip as a source of vitamin C, vitamin E, and Piper longum standardized in piperine.
The formulation uses a plant-based capsule, consistent with a choice aimed at a vegan product.
Garcinia cambogia and hydroxycitric acid
Garcinia cambogia has been studied especially in the context of body weight control and energy metabolism.
Its main bioactive compound is hydroxycitric acid, or HCA.
One of the proposed mechanisms involves the interaction with ATP-citrate lyase, an enzyme involved in the availability of citrate for fatty acid synthesis.
Indirect interactions with the mechanisms that regulate appetite and eating behavior have also been proposed.
A meta-analysis has suggested that Garcinia extracts can produce modest effects on body weight, but the magnitude of the effect and the quality of the available studies require a cautious interpretation.
In Dimaloe, Garcinia should not be considered a substance capable of automatically producing weight loss. Its rationale must be included in a program that includes energy intake control and physical activity.
Gymnema sylvestre and carbohydrate metabolism
Gymnema sylvestre is one of the most interesting extracts from the perspective of the relationship between botanicals and carbohydrate metabolism.
Its main components include gymnemic acids.
Experimental studies have proposed several mechanisms: modulation of intestinal carbohydrate absorption, interaction with the perception of sweet taste, and possible effects on glucose metabolism.
One of the most characteristic effects of Gymnema concerns the temporary modification of the perception of sweet taste, a phenomenon attributed to the interaction of its constituents with receptors involved in the perception of sugars.
In the nutritional protocol, the presence of Gymnema therefore contributes to the rationale of supporting carbohydrate metabolism.
However, in patients treated with hypoglycemic drugs or insulin, the combination of substances potentially active on carbohydrate metabolism requires particular attention and medical evaluation.
Green coffee and chlorogenic acid
The Coffea arabica extract contained in Dimaloe provides chlorogenic acid and a very low amount of caffeine.
Chlorogenic acids have been studied for their possible influence on intestinal glucose absorption and liver metabolism.
The amount of caffeine indicated in the formulation is only 4 mg per daily dose, therefore the rationale for green coffee is mainly linked to the presence of the standardized extract and chlorogenic acid rather than a stimulating effect of caffeine.
Maitake and polysaccharides
Maitake, Grifola frondosa, contains polysaccharides that have been studied for their interactions with the immune system and metabolism.
The available evidence on its direct clinical use in diabetes is still limited compared to other established interventions.
Its presence in the formulation therefore contributes to a multi-component approach, but should not be interpreted as a demonstration of therapeutic efficacy against diabetes.
Griffonia, 5-HTP and eating behavior
Griffonia simplicifolia is used as a source of 5-hydroxytryptophan, a precursor of serotonin.
Serotonin plays a role in regulating eating behavior and satiety mechanisms.
The rationale for the presence of 5-HTP in a formulation dedicated to weight and appetite control is therefore linked to the possible influence on the neurochemical circuits involved in the choice and quantity of food.
However, attention must be paid to possible drug interactions.
5-HTP should not be taken without medical advice in case of therapy with antidepressants or other drugs that act on the serotonergic system.
Rosehip, vitamin C and vitamin E
Dimaloe provides 35 mg of vitamin C, corresponding to 43% of the Reference Nutrient Value, and 9 mg of vitamin E, equal to 75% of the NRV.
Vitamin C and vitamin E contribute to the protection of cells from oxidative stress according to the claims authorized by European regulations.
In the metabolic context, protection from oxidative stress represents an element of interest because persistent hyperglycemia, lipid alterations and metabolic dysfunction can be associated with an increase in oxidative processes.
The contribution of vitamins should not, however, be interpreted as prevention or treatment of diabetic complications.
Piper longum and bioavailability
Dimaloe contains Piper longum extract standardized in piperine.
Piperine has been studied for its ability to modify the absorption and metabolism of various substances.
This represents the rationale for its presence as a component intended to support the bioavailability of certain phytochemicals.
Precisely for this ability, piperine deserves particular attention in subjects undergoing pharmacological treatment, because it could theoretically modify the pharmacokinetics of certain medicines.
Why Dimaloe can be distributed in relation to meals
The choice between the 2 capsules at breakfast and 2 capsules at lunch or 2 capsules at breakfast and 2 capsules at dinner scheme allows the intake to be adapted to the daily distribution of meals.
When dinner is light, the concentration of the intake during breakfast and lunch may be more consistent with the greater food intake of the day.
When, on the other hand, lunch is frugal and dinner constitutes the most substantial meal, the distribution between breakfast and dinner may be more consistent with the individual eating routine.
This approach does not mean that the supplement should be used to compensate for particularly abundant or sugar-rich meals.
The most important rationale remains the construction of balanced meals, with an adequate amount of protein, fiber and plant foods and with an appropriate quality of carbohydrates.
A protocol that always starts with lifestyle
The association between LUNAE and Dimaloe must be considered within an overall strategy.
The first level remains composed of nutrition. In subjects with alterations in carbohydrate metabolism, it is generally useful to favor foods rich in fiber, legumes, vegetables, whole grains in appropriate quantities and quality protein sources.
The second level is represented by movement.
Aerobic activity improves the utilization of glucose, while resistance exercise contributes to the maintenance and increase of muscle mass, an important metabolic compartment for glucose uptake.
The third level concerns continuity.
A change that is sustainable over time is generally more important than an extremely restrictive intervention maintained for a few weeks.
In this perspective, LUNAE and Dimaloe can be included as nutritional support within a broader program, but they cannot replace the fundamental pillars of prevention and metabolic management.
PLEASE NOTE
The information present in the product sheets on this site is exclusively for informational and educational purposes and does not represent a medical opinion. The published contents are not intended to replace the relationship with the doctor nor any medical indications, diagnoses or prescriptions. The reported information describes the ingredients and characteristics of food supplements, designed as support for the balance and well-being of the organism within a healthy lifestyle. Food supplements are not medicines and should not be used to prevent, diagnose, treat or alleviate diseases or pathological conditions.
Bibliographic references
American Diabetes Association Professional Practice Committee. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2026. Diabetes Care. 2026.
Umpierre D, Ribeiro PAB, Kramer CK, et al. Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes. JAMA. 2011;305:1790-1799.
Spadafranca A, Rinelli S, Riva A, et al. Phaseolus vulgaris extract affects glycometabolic and appetite control in healthy human subjects. British Journal of Nutrition. 2013;109:1789-1795.
Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nature Medicine. 2004;10:1344-1351.
Zhang Y, Li X, Zou D, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. Journal of Clinical Endocrinology and Metabolism. 2008;93:2559-2565.
Varilla V, Atkinson C, Brodsky M. Bromelain: a review of its anti-inflammatory properties and clinical applications. Evidence-Based Complementary and Alternative Medicine. 2021.
Walker AF, Bundy R, Hicks SM, Middleton RW. Bromelain reduces mild acute knee pain and improves well-being in a dose-dependent fashion. Phytomedicine. 2002.
Kimmatkar N, Thawani V, Hingorani L, Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee. Phytomedicine. 2003;10:3-7.
Yu G, Xiang W, Zhang T, et al. Clinical efficacy and safety of Boswellia serrata in osteoarthritis: a systematic review and meta-analysis. BMC Complementary Medicine and Therapies. 2020.
Daily JW, Yang M, Park S. Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: a systematic review and meta-analysis. Journal of Medicinal Food. 2016;19:717-729.
Sahebkar A, Cicero AFG, Simental-Mendía LE, Aggarwal BB, Gupta SC. Curcumin downregulates human tumor necrosis factor-alpha levels: a systematic review and meta-analysis of randomized controlled trials. Pharmacological Research. 2016.
Heymsfield SB, Allison DB, Vasselli JR, Pietrobelli A, Greenfield D, Nunez C. Garcinia cambogia extract for weight loss: a randomized clinical trial. JAMA. 1998;280:1596-1600.
Onakpoya I, Hung SK, Perry R, Wider B, Ernst E. The use of Garcinia extract as a weight loss supplement: a systematic review and meta-analysis of randomised clinical trials. Journal of Obesity. 2011;2011:509038.
Baskaran K, Ahamath BK, Shanmugasundaram KR, Shanmugasundaram ERB. Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients. Journal of Ethnopharmacology. 1990;30:295-300.
Leach MJ. Gymnema sylvestre for diabetes mellitus: a systematic review. Journal of Alternative and Complementary Medicine. 2007.
Vinson JA, Burnham BR, Nagendran MV. Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects. Diabetes, Metabolic Syndrome and Obesity. 2012;5:21-27.
Cangiano C, Ceci F, Cairella M, et al. Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan. American Journal of Clinical Nutrition. 1992;56:863-867.
Srinivasan K. Black pepper and its pungent principle-piperine: a review of diverse physiological effects. Critical Reviews in Food Science and Nutrition. 2007;47:735-748.
Regulation (EC) No 1924/2006 on nutrition and health claims made on foods.
Regulation (EU) No 432/2012 laying down a list of permitted health claims on foods.
Directive 2002/46/EC on the approximation of the laws of the Member States relating to food supplements.
